




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Latest in Cardiology</title>
        <link>http://www.acc.org/Feed/LatestCardiology?topicID=8d7f3960-0beb-4a23-b87d-661262d0bb4f</link>
        <description>ACC Feed: Latest in Cardiology</description>
        <language>en</language>

        


                <item>
                    <title>Did Disparities in ICD Implantations Worsen During the COVID-19 Pandemic? | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/15/14/32/Did-Disparities-in-ICD-Implantations-Worsen</link>                    <description>The incidence of ICD implantations declined significantly during the COVID-19 pandemic, according to a recent study published in Heart Rhythm. Although disparities by sex, race and ethnicity persisted during peak COVID, they did not worsen.</description>
                    <pubdate>1778884980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AFib Ablation Approaches Differ by Hospital Teaching Status | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/15/14/32/AFib-Ablation-Approaches-Differ-by-Hospital-Teaching-Status</link>                    <description>Procedural approaches for atrial fibrillation (AFib) ablation differ by hospital teaching status; however, overall complication rates are similar, according to a recent study published in JAHA.</description>
                    <pubdate>1778884980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: The Evolving Role of PCSK9 Inhibitors in LDL-C Management</title>
<link>/Latest-in-Cardiology/Articles/2026/05/14/13/14/cardiacast_15may2026</link>                    <description>In this episode of CardiaCast, Dr. Michael Blaha will be joined by Dr. Ann Marie Navar to discuss the 2026 updates to ACC/AHA guideline on management of dyslipidemia and key clinical trial data supporting the use of PCSK9 inhibitors in getting patients to their lipid goals.</description>
                    <pubdate>1778859000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Obesity Emerges as Independent Risk Factor For New-Onset HF, Mortality</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/14/17/42/Clinical Obesity</link>                    <description>A cohort study published May 4 in JACC: Asia identified clinical obesity as a risk factor for new-onset heart failure (HF) and all-cause mortality, largely due to related clinical conditions and excess weight. Treating clinical obesity as an independent disease may increase the effectiveness of HF prevention strategies.</description>
                    <pubdate>1778782020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ALLEPRE: Nurse-Coordinated Prevention Program May Reduce Long-Term CV Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/13/18/45/ALLEPRE</link>                    <description>Implementing a nurse-coordinated prevention program (NCPP) significantly reduced long-term major adverse cardiovascular events (MACE) and improved body weight control, physical activity and pharmacotherapy adherence in post-hospitalization patients with acute coronary syndrome (ACS), according to results from the ALLEPRE trial published May 5 in EHJ.</description>
                    <pubdate>1778699220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Rising HDP Rates in the US; BP Monitoring Across the Lifespan</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Rising-HDP-Rates-in-the-US</link>                    <description>The rate of new-onset hypertensive disorders of pregnancy (HDP) in the U.S. increased significantly from 2016 to 2024 across all racial and ethnic groups, according to a brief JACC report &#226;€“ the importance of which is further echoed in a longer systematic review of blood pressure (BP) monitoring across a patient&#39;s lifespan published in JACC&#39;s May 12 hypertension focus issue.</description>
                    <pubdate>1778688120000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Ivabradine vs. Propranolol For POTS; Testosterone Prescribing Trends</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Ivabradine-vs-Propranolol</link>                    <description>Both ivabradine and propranolol reduced tachycardia and symptoms of postural orthostatic tachycardia syndrome (POTS), compared with placebo, based on findings from a randomized, double-blind crossover trial published in JACC and JACC: Advances.</description>
                    <pubdate>1778688060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: Can Rhythm Control Improve Tricuspid Regurgitation? </title>
<link>/Latest-in-Cardiology/Articles/2026/05/12/15/21/eagles-eye-view-13may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle examines the role of rhythm control in improving moderate-to-severe and severe secondary tricuspid valve regurgitation.</description>
                    <pubdate>1778679000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FASTR: Reprieve System Safely Accelerates Decongestion in Acute HF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/FASTR</link>                    <description>The Reprieve System, a three-part approach to diuretic therapy, safely produced significantly faster decongestion in patients with acute heart failure (HF) compared with optimal diuretic therapy (ODT), according to results of the FASTR trial published May 4 in JACC: Heart Failure.</description>
                    <pubdate>1778670960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>